New Research on Meningitis Vaccine: Effects, Side Effects and The Latest on the Market

Side Meningitis vaccine Effects The Effects of Bacterial Meningitis: Many people may have heard of meningitis, an infection of the spinal cord and brain fluid. In fact, many people probably also know the seriousness of this infectious disease. If left untreated, bacterial meningitis can lead to seizure, brain damage and even death.

However, there is no need to lock your children up in fear of contacting meningitis. For starters, the disease is actually very uncommon. You cannot contact meningitis simply by breathing in the air of an infected person. You can, however, contact meningitis by coming into close contact with the nose and throat discharges of an infected person.

With this in mind, meningitis, although quite uncommon, still poses a major threat, especially in children. This is why many opt for the meningitis vaccine as a way to prevent their children from contacting this serious infectious disease.

Common Side Effects of the Meningitis Vaccine: Bacterial meningitis can have dire consequences. About 5-10 per cent of people who contact bacterial meningitis die from it. A further 11-19 per cent of people experience a loss of hearing, problems with their nervous systems, mental retardation, seizures, strokes or a loss of their arms and legs. Bacterial meningitis can come on strong which is another reason why meningitis vaccines are so important.

Everyone who undergoes a vaccination will have a different reaction. While some will have no side effects, other may develop a slight fever or experience an allergic reaction. This can include hives, dizziness, swelling, and a high fever. You may also feel weak and tired and experience muscle aches and tenderness.

Children may experience tenderness and redness around the injection area. This is completely normal for all vaccinations, meningococcal and otherwise.

New Research on the Meningitis Vaccine: Who is at Risk?: The latest research on bacterial meningitis suggests that those most at risk for bacterial meningitis are children and college students living in dormitories. However, anyone can contact the infection. You may also be at a higher risk, and should consider vaccination if you are travelling to Africa, are prone to immune deficiency disorders, have a damaged, or removed spleen or work in a childcare center.

Menomune, Menactra and Menjugate Vaccines: There are two main meningococcal vaccines currently available in the United States: Menomune, which has been around since the 1970′s and Menactra, a newer vaccination licensed in 2005.

Both vaccines can prevent the four most common types of meningococcal disease found in America and in Africa. However, neither can prevent from all strains of the disease. These vaccines can also prevent the spreading of the disease and are 90 percent effective in protecting those who contact meningitis.

In Canada, the most common vaccine for meningitis is Menjugate which protects against Group C, the most common type of meningococcal disease. The vaccination is most commonly given to infants under one year of age. In infants, a series of three doses is recommended. Menjugate is also used for protecting adults and adolescence. However, only one single dose is required.

The costs of these shots can vary depending on your health care plan. Consult your doctor for the best prevention options. Protecting yourself and your children from this serious infection is only a booster shot away.